What is Global Cardiac Biomarkers Testing Market?
The Global Cardiac Biomarkers Testing Market is a comprehensive sector that focuses on the identification and measurement of certain proteins and enzymes released by the heart when it is damaged or stressed. These biomarkers are used to diagnose various heart conditions such as myocardial infarction, congestive heart failure, acute coronary syndrome, and atherosclerosis. The market was valued at US$ 7132.7 million in 2023 and is projected to reach a significant value of US$ 11410 million by 2030. This growth is expected to occur at a Compound Annual Growth Rate (CAGR) of 6.5% during the forecast period of 2024 to 2030. The market's expansion is driven by the increasing prevalence of cardiovascular diseases, advancements in technology, and the growing demand for quick and accurate cardiac testing. The market also benefits from the rising awareness about the importance of early diagnosis and treatment of heart diseases. However, the high cost of cardiac biomarker testing and the lack of skilled professionals are some of the challenges that the market faces. Despite these challenges, the Global Cardiac Biomarkers Testing Market continues to show promising growth, providing numerous opportunities for existing players and new entrants alike.
Myocardial Muscle Creatine Kinase (CK-MB), Troponins (T and I), Myoglobin, Brain Natriuretic Peptide (BNPs) or NT-proBNP, Ischemia-modified Albumin (IMA), Others in the Global Cardiac Biomarkers Testing Market:
English: #CardiacBiomarkers #HeartHealth #CardiacTesting #MarketGrowth #HealthcareInnovation #EarlyDiagnosis #Treatment #CardiovascularDiseases #GlobalMarket #HealthcareTechnology
Myocardial Infarction, Congestive Heart Failure, Acute Coronary Syndrome, Atherosclerosis, Others in the Global Cardiac Biomarkers Testing Market:
Japanese: #心臓バイオマーカー #心臓健康 #心臓検査 #市場成長 #ヘルスケアイノベーション #早期診断 #治療 #心血管疾患 #グローバルマーケット #ヘルスケアテクノロジー
Global Cardiac Biomarkers Testing Market Outlook:
Korean: #심장생물학적표지자 #심장건강 #심장검사 #시장성장 #헬스케어혁신 #조기진단 #치료 #심혈관질환 #글로벌시장 #헬스케어기술
| Report Metric | Details |
| Report Name | Cardiac Biomarkers Testing Market |
| Accounted market size in 2023 | US$ 7132.7 million |
| Forecasted market size in 2030 | US$ 11410 million |
| CAGR | 6.5% |
| Base Year | 2023 |
| Forecasted years | 2024 - 2030 |
| Segment by Type |
|
| Segment by Application |
|
| By Region |
|
| By Company | Abbott Laboratories, Becton, Dickinson and Company, BioMerieux, Bio-Rad Laboratories, Inc., Danaher Corporation, ROCHE, Siemens AG, Thermo Fisher Scientific, Inc., PerkinElmer Inc., Tosoh Corporation |
| Forecast units | USD million in value |
| Report coverage | Revenue and volume forecast, company share, competitive landscape, growth factors and trends |
